全球感染性疾病治疗市场分析报告.pptVIP

11 PHM061A — Infectious Disease Treatments: Global Markets The following table estimates the vaccine sales for infectious diseases, by manufacturer in 2008, along with approximate market share. TABLE 3 ESTIMATED VACCINE SALES FOR INFECTIOUS DISEASES, BY MANUFACTURER, 2008 (%/$ MILLIONS) Approximate Manufacturer Sanofi Pasteur MSD Pfizer-Wyeth AstraZeneca/MedImmune GlaxoSmithKline Merck Novartis Berna (Crucell) Solvay Other manufacturers Total % of Market .6 .2 .8 .2 .8 .0 .6 .1 .7 .0 $ Millions .0 .0 .0 .0 .0 .0 .4 .2 .0 .6 Source: European Vaccine Manufacturers, BCC Research, company reports Analysis by a leading vaccine-producing company estimates that the vaccine market is the fastest-growing segment of the healthcare market. The total vaccine market was estimated at more than $17 billion in 2008 and is estimated to grow to $33.5 billion by 2014. For the first time in 2009, adult vaccines are projected to garner more revenue than pediatric vaccines. The following table projects the growth of the total vaccine market, through 2014. This segment of the healthcare market is one of the fastest growing at a 5-year CAGR of 10.3%. Copyright ? BCC Research, Wellesley, MA USA, Web: 12 PHM061A — Infectious Disease Treatments: Global Markets TABLE 4 PROJECTED SALES OF VACCINES TO TREAT INFECTIOUS DISEASES WORLDWIDE, THROUGH 2014 ($ BILLIONS) CAGR% 2008 17.8 2009 20.5 2010 23.6 2014 .5 2009-2014 .3 Source: BCC Research, industry reports After an infection occurs, prompt treatment is imperative to prevent further transmission and potential death of the individual. In the case of the leading infectious diseases, antiviral or antibiotic treatments may be used. In some cases, no treatment other than time, isolation, and aseptic practices exists. The following table outlines some of the treatment modalities for the most persistent infectious diseases. TABLE 5 SELECTED TREATMENT MODALITIES